MYMusa Yilmaz

Musa Yilmaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Musa Yilmaz has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Alarin as a potential biomarker in childhood obesity: Evidence from a case-control study

    by Ilknur Kaba, Musa Yilmaz, Havva Nur Peltek Kendirci

    Studies on Alarin, a newly identified orexigenic adipokine, have mainly focused on adults, while research investigating Alarin levels and its association with obesity in children remains limited. The aim of this study was to measure Alarin levels in children and adolescents with obesity and investigate their relationship with various metabolic parameters, as well as explore how these associations may differ by age group and gender. This prospective case-control study included 30 children with obesity (body mass index [BMI] standard deviation score [SDS] > +2) and 49 age- and gender-matched controls (BMI SDS between −1.9 and +1.9). Participants were recruited at the pediatric endocrinology outpatient clinic between April 2022 and April 2023. Clinical data, including chronological age, physical examination findings, and laboratory test results (alanine transaminase [ALT], aspartate transaminase [AST], total cholesterol, triglycerides, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], fasting blood glucose, and insulin levels), were collected from the hospital’s information management system. The presence and severity of hepatosteatosis were assessed by abdominal ultrasound. Insulin resistance (IR) was determined using the HOMA-IR index, with a cutoff value of 2.5 for prepubertal patients and 3.16 for pubertal patients. The mean age of the participants was 11.6 ± 3.5 years (range: 4.5–17.7 years), with 58.2% (n = 46) being female. Serum Alarin, LDL-C, γ-glutamyl transferase (GGT), insulin, and HOMA-IR levels were significantly higher in the obesity group ( P < .05). In the obese group, Alarin levels showed positive correlations with age, BMI SDS, fasting glucose, and presence of hepatic steatosis ( P < .05). No significant correlations were found in the control group. The study found elevated Alarin levels in children and adolescents with obesity, similar to previous findings in adults. This suggests that Alarin may play a role in energy homeostasis and insulin resistance in childhood obesity. The results contribute to a deeper understanding of obesity’s molecular mechanisms of obesity and may help to identify new therapeutic targets for preventing obesity-related complications and metabolic diseases.

  • Open Access

    Heterophile antibody interference in cardiac biomarker testing: mechanisms, pitfalls, and clinical consequences

    by Ömer Burak Çelik, Macit Kalçık, Abdullah Sarıhan, Mehmet Mustafa Yılmaz, Osman Karaarslan, Mucahit Yetim, Muhammet Cihat Çelik, Lütfü Bekar, Musa Yılmaz, Yusuf Karavelioğlu

    High-sensitivity cardiac biomarkers have transformed modern cardiology by enabling earlier diagnosis and refined risk stratification in acute coronary syndromes and heart failure. However, increasing analytical sensitivity has also amplified the clinical impact of immunoassay interferences, particularly those caused by heterophile antibodies. These endogenous antibodies can interact with assay antibodies and generate false-positive or false-negative results, most notably in sandwich immunoassays used for cardiac troponins and natriuretic peptides. Persistent, clinically implausible biomarker elevations related to heterophile antibody interference have led to unnecessary invasive procedures, inappropriate pharmacologic treatment, repeated hospital admissions, and prolonged diagnostic uncertainty. Conversely, false-negative results may delay diagnosis, result in inappropriate discharge, and contribute to adverse clinical outcomes in high-risk patients. This review summarizes the immunological basis and analytical mechanisms of heterophile antibody interference, highlights cardiac biomarkers most commonly affected, and outlines key clinical red flags that should prompt suspicion. Practical laboratory strategies include polyethylene glycol precipitation as an initial approach to detect antibody-mediated interference, followed by dilution studies, heterophile blocking reagents, and cautiously interpreted alternative platform testing within assay-specific reference frameworks, together with close clinician-laboratory collaboration. Greater awareness of analytical interference is critical as cardiology becomes increasingly biomarker-driven. Integrating clinical judgment with structured laboratory verification can substantially reduce diagnostic error, improve patient safety, and prevent avoidable healthcare utilization in contemporary cardiovascular practice.


  • Open Access

    Nocturnal Melatonin Deficiency in Colorectal Cancer: Independent Predictive Value Beyond Sleep Quality

    by Ibrahim Durak, Busra Durak, Tolga Duzenli, Musa Yilmaz, Muhammed Kaya, Mustafa Sadecolak, Huseyin Koseoglu, Duygu Ozol

    Background/Aim: Melatonin is a cytoprotective hormone with antioxidant activity and also mediates regulatory effects that inhibit tumor proliferation and angiogenesis. This study aimed to evaluate serum melatonin levels and sleep quality in patients with newly diagnosed colorectal cancer (CRC) compared with controls and to investigate whether melatonin could serve as a potential biomarker. Materials and Methods: A total of 71 participants (36 CRC, 35 controls) were included. Blood samples were obtained between 01:00- 02:00 am and serum melatonin was measured using a high-sensitivity (ELISA) Enzyme-Linked Immunosorbent Assay kit. Sleep quality was assessed with the Pittsburgh Sleep Quality Index (PSQI) and sleep apnea risk was determined by the STOP-Bang questionnaire. Group comparisons were performed, followed by multivariable logistic regression and receiver-operating characteristic analysis. Results: Colorectal cancer patients had significantly lower nocturnal serum melatonin concentrations (131.1 Å} 35.5 vs. 194.8 Å} 50.8 pg/ mL, P < .001) and higher PSQI scores (5.6 Å} 3.1 vs. 5.1 Å} 3.0, P = .028). In multivariable analysis, melatonin remained the only independent predictor of CRC (OR = 0.952, 95% CI: 0.929-0.976, P < .001). Receiver-operating characteristic analysis identified a melatonin threshold of ~150 pg/mL, discriminating CRC patients from controls with 75% sensitivity and 91.4% specificity (AUC = 0.877). Conclusion: Although cancer patients and the control group showed comparable obstructive sleep apnea risk, sleep quality was poorer, and melatonin levels were significantly lower in the cancer group. Melatonin assessment can complement traditional risk stratification and may provide new insights into the interplay between circadian biology, sleep, and colorectal carcinogenesis. Cite this article as: Durak I, Durak B, Duzenli T, et al. Nocturnal melatonin deficiency in colorectal cancer: independent predictive value beyond sleep quality. Turk J Gastroenterol. Published online February 23, 2026. doi: 10.5152/tjg.2026.25808.


  • Open Access

    Comparison of Siemens Rapidlab 1200 blood gas analyzers and Beckman Coulter AU680 laboratory auto analyzers for sodium, potassium, hemoglobin and hematocrit parameters in emergency departments patients

    by Serkan Günay, Ahmet Öztürk, Arda Tuna Pakkan, Anılcan Tahsin Karahan, Halil İbRahim Tekeli, Elif Özbek, Musa Yılmaz, Seval Komut, Yavuz Yiğit

    Blood gas analyzers (BGAs) offer rapid results and operational convenience in emergency settings, whereas laboratory auto analyzers (LAAs) remain the reference standard despite slower processing. This study compared BGA and LAA measurements of sodium (Na), potassium (K), hemoglobin (Hb), and hematocrit (Hct). A secondary aim was to evaluate their agreement across acid-base subgroups and in cases of severe acidosis. This study included ≥18 years patients from January 1 to June 30, 2024. BGA and LAA results were compared overall and across acid-base subgroups. Patients with pH <7.20 were analyzed separately as the severe acidosis group. Bland-Altman analysis showed the following mean differences and 95% limits of agreement: Na, 1.36 ± 2.33 mmol/L (-3.21 to 5.92); K, 0.221 ± 0.197 mmol/L (-0.166 to 0.607); Hb, 0.531 ± 0.649 g/dL (-0.742 to 1.804); and Hct, 1.68% ± 2.60 (-3.42 to 6.78). At clinical decision thresholds, BGA demonstrated varying diagnostic performance with sensitivities and specificities of 56.9% and 95.8% for hyponatremia, 67.5% and 98.7% for hypernatremia, 95.4% and 95.6% for hypokalemia, 48.7% and 99.8% for hyperkalemia, and 73.4% and 99.9% for transfusion decisions, respectively. In patients with severe acidosis, correlations remained strong, though agreement limits were notably wider. BGA-derived K values showed acceptable agreement with LAA and may be used interchangeably. Hb and Hct did not meet agreement criteria, while Na may be acceptable with clinical correlation. In severe acidosis, none of the parameters achieved acceptable agreement, indicating that BGA results should be interpreted with caution in this subgroup.